glp-1 obesity drug news oct 21 2025 How Supply and Demand for Weight Loss Drugs is Playing Out in 2026 GLP-1 Agonists Weight Loss Drugs

doi: 10.1097/CCE.0000000000001247

Once pharmacological treatment is initiated and proves effective, it should not be arbitrarily time-limitedjust as we would not discontinue treatment for diabetes, hypertension, or other chronic diseases

How would the addition of a GLP-1RA compare to other second-line add-on therapies in improving management of the T2DM

While companies might show testimonials or before-and-after photos, there are no peer-reviewed clinical trials demonstrating effectiveness

And then some people are turning to more dubious sources for the drugs rather than shelling out full price for the branded versions